Financially Strong And High Growth Stocks
Individual investors like stocks with a high growth potential. These companies have a strong outlook that can bring a significant upside to your portfolio, regardless of market cyclicality. If your holdings could benefit from diversification towards growth stocks, whether it be in reputable tech stocks or green small-caps, take a look at my list of stocks with a bright future ahead.
Dycom Industries, Inc. (NYSE:DY)
Dycom Industries, Inc. provides specialty contracting services in the United States and Canada. Formed in 1969, and currently headed by CEO Steven Nielsen, the company employs 14,607 people and with the company’s market cap sitting at USD $2.89B, it falls under the mid-cap stocks category.
DY’s projected future profit growth is a robust 27.57%, with an underlying 35.62% growth from its revenues expected over the upcoming years. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a high double-digit return on equity of 21.19%. DY’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Want to know more about DY? Have a browse through its key fundamentals here.
Loma Negra Compañía Industrial Argentina Sociedad Anónima (NYSE:LOMA)
Loma Negra Compañía Industrial Argentina Sociedad Anónima, together with its subsidiaries, manufactures and markets cement and its by-products in Argentina and Paraguay. Started in 1926, and run by CEO Sergio Faifman, the company size now stands at 3,258 people and with the market cap of USD $1.81B, it falls under the small-cap group.
LOMA is expected to deliver a buoyant earnings growth over the next couple of years of 22.22%, bolstered by an equally impressive revenue growth of 65.32%. It appears that LOMA’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 71.41%. LOMA’s impressive outlook on all aspects makes it a worthy company to spend more time to understand. Should you add LOMA to your portfolio? Have a browse through its key fundamentals here.
Clearside Biomedical, Inc. (NASDAQ:CLSD)
Clearside Biomedical, Inc., a late-stage clinical biopharmaceutical company, develops pharmacological therapies to treat blinding diseases of the eye. Established in 2011, and run by CEO Daniel White, the company size now stands at 34 people and with the stock’s market cap sitting at USD $422.34M, it comes under the small-cap group.
CLSD’s forecasted bottom line growth is an optimistic double-digit 30.96%, driven by underlying sales, which is expected to more than double, over the next few years. It appears that CLSD’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. CLSD’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Want to know more about CLSD? Other fundamental factors you should also consider can be found here.
For more financially robust companies with high growth potential to enhance your portfolio, explore this interactive list of fast growing companies.
To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned.
